Month: July 2023

CENTREVILLE, Va., July 10, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE:PSN) will release second quarter 2023 financial results before the markets open on Wednesday, August 2, 2023. The company will host a conference call at 8:00 a.m. Eastern Time that day to discuss its earnings results and strategic corporate initiatives. Access to a webcast of the live conference call can be obtained through the Investor Relations section of the company’s website (https://investors.parsons.com). Those parties interested in participating via telephone may register on the Investor Relations website or by clicking here. A replay will be available on the company’s website approximately two hours after the conference call and continuing for one year. About Parsons Corporation Parsons (NYSE: PSN) is a leading disruptive technology...

BOSTON HEIGHTS, Ohio, July 10, 2023 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a rapidly growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, will release its second quarter 2023 financial results before market open on Wednesday, August 9, 2023. The Company will host a conference call at 8:30 a.m. Eastern Time the same day to review its financial and operational results and answer questions from the investment community. Investors will be able to access the press release and conference call webcast on the Company’s website, http://ir.arhaus.com.Details for the conference call follow:Date:   Wednesday, August 9, 2023Time:   8:30 a.m. Eastern Time     To listen via the internet:The call will be webcast on the Investor Relations section of the Company’s website, http://ir.arhaus.com. To...

NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) — MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it has rescheduled its earnings conference call to Wednesday August 2, 2023, at 5 p.m. Eastern Time. As previously announced, the Company will report results for the quarter ended June 30, 2023, after market close on Wednesday, August 2, 2023. The Company will host a conference call on Wednesday, August 2, 2023, at 5:00 p.m. Eastern Time. All interested parties are welcome to participate in the conference call by dialing (800) 343-4849 approximately 5-10 minutes prior to the call; international callers should dial (203) 518-9783. Participants should reference either MidCap Financial Investment Corporation Earnings or Conference ID: MFIC0802 when prompted. A simultaneous webcast of the conference...

Preliminary Data Suggest that Oxytocin May Simultaneously Reduce Energy Intake and Increase Energy Expenditure TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine Weight-Loss Therapeutic for this Patient Population CHATHAM, N.J., July 10, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the first participant was enrolled in the Phase 2 ‘POWER’ study of TNX-1900 (intranasal potentiated oxytocin) for the treatment of pediatric obesity at the Massachusetts General Hospital (MGH). The aim of the study is to investigate the efficacy and safety of TNX-1900 as a novel therapeutic agent to induce weight loss and improve indicators of cardiometabolic risk in adolescent patients with obesity. Tonix...

TORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Halcones Precious Metals Corp. (TSX – V: HPM) (the “Company” or “Halcones”) announces that its wholly-owned subsidiary, Minera Los Halcones SpA, has made the scheduled option agreement payment pursuant to the option agreement (the “Option Agreement”) to maintain its option to acquire the Carachapampa project (the “Project”). As previously announced, Halcones and the optionor agreed to extend the deadline to make the next payment of USD$200,000 from April 7, 2023 to July 7, 2023 (Please see Halcones’ news release dated April 4, 2023). The extension enabled additional time for the Halcones technical team to fully evaluate the results of the recent 7 hole (1,526 m) drill campaign. With the additional analysis now complete, Halcones has paid the scheduled amount in full. Drill campaign highlights: Hole...

– Jay S. Duker, M.D., Previously President and Chief Operating Officer, Appointed President and Chief Executive Officer – – Nancy S. Lurker Transitions to Executive Vice Chair of the Board of Directors Pursuant to Long Term Succession Plan – WATERTOWN, Mass., July 10, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Jay S. Duker, M.D. as Chief Executive Officer (CEO). Dr. Duker has transitioned from his most recent role as Chief Operating Officer (COO) and President. Dr. Duker has also been appointed to the Board of Directors of the Company, effective today. Nancy S. Lurker has transitioned to the role of Executive Vice Chair of the Board of Directors...

BOSTON, July 10, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been dosed in the phase 1/2 trial of TNG462 in patients with MTAP-deleted solid tumors. TNG462 is a potentially best-in-class MTA-cooperative PRMT5 inhibitor previously granted Fast Track designation by the U.S. Food and Drug Administration. The TNG462 phase 1/2 clinical trial will evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy of TNG462 in solid tumors with MTAP deletions. “Dosing the first patient with our next-generation MTA-cooperative PRMT5 inhibitor, TNG462, demonstrates our deep commitment to developing transformative treatments for patients with MTAP-deleted cancers....

TORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Canadian North Resources Inc. (“the Company,” TSXV: CNRI; OTCQX: CNRSF; FSE: EO0 (E-O-zero)) is pleased to announce that Director and Chairman of the Company, Mr. Lee Shim purchased 100,000 shares of the Company’s common stock in the open market at a price of $2.20 per share. Complete details are available at SEDI.ca. This investment further reinforces Mr. Shim’s confidence in the Company’s growth potential and commitment to its long-term success. About Canadian North Resources Canadian North Resources Inc. is an exploration and development company focusing on the critical metals for the clean-energy, electric vehicles, battery and high-tech industries. The company is advancing its 100% owned Ferguson Lake nickel, copper, cobalt, palladium, and platinum project that...